General pharmacology of KB-944, a new calcium antagonist
Morita, T.; Fukuda, T.; Sukamoto, T.; Tajima, S.; Sato, I.; Ikeda, Y.; Kanazawa, T.; Hamada, Y.; Morimoto, Y.; Kitamura, H.; Kawakami, K.; Ito, K.; Nose, T.
Arzneimittel-Forschung 32(9): 1060-1068
1982
ISSN/ISBN: 0004-4172 PMID: 6890827 Document Number: 188269
Document emailed within 1 workday
Related Documents
Krivonkin, K.I.; Belousov, I.B. 1991: Clinical pharmacology of nisoldipine, a new calcium antagonist Kardiologiia 31(9): 100-105Lee, J.Y.; Rozek, L.F.; Sanner, J.H.; Radzialowski, F.M. 1983: Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552 Methods and Findings in Experimental and Clinical Pharmacology 5(4): 235-249
Terai, T.; Kusunoki, T.; Kita, Y.; Yoshida, K.; Akahane, A.; Shiokawa, Y.; Kohno, Y.; Horiai, H.; Mori, J.; Mine, Y.; Kohsaka, M. 1996: General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol Arzneimittel-Forschung 46(2): 185-191
Säfholm, C.; Havu, N. 1993: General toxicity of the new calcium antagonist felodipine in dogs Arzneimittel-Forschung 43(7): 729-733
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401
Matsuda, S. 1991: Protective effects of calcium antagonist (nitrendipine) on calcium ionophore A23187-induced liver cell injury Bulletin of Tokyo Medical and Dental University 38(3): 35-44
Upward, J.W.; Arnold, B.D.; Link, C.; Pierce, D.M.; Allen, A.; Tasker, T.C. 1990: The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist European Journal of Cancer 26(Suppl 1): S12-S15
Cohen, M.L.; Fuller, R.W.; Kurz, K.D.; Parli, C.J.; Mason, N.R.; Meyers, D.B.; Smallwood, J.K.; Toomey, R.E. 1988: Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067 Journal of Pharmacology and Experimental Therapeutics 244(1): 106-112
Brittain, R.T.; Daly, M.J. 1981: A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist Scandinavian Journal of Gastroenterology. Suppl 69: 1-9
Poizot, A.; Dumez, D.; Ferrandon, P.; Lefournier, C.; Michel, A.; Armstrong, J.M. 1986: Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline Arzneimittel-Forschung 36(4): 695-702
Engelhardt, G. 1975: On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist Arzneimittel-Forschung 25(11): 1723-1737
Paraskos, J.A. 1986: Cardiovascular pharmacology. III: Atropine, calcium, calcium blockers, and beta-blockers Circulation 74(6 Part 2): Iv86-Iv89
Clavijo, G.A.; de Clavijo, I.V.; Weart, C.W. 1994: Amlodipine: a new calcium antagonist American Journal of Hospital Pharmacy 51(1): 59-68
Opie, L.H.; Muller, C.A.; Thandroyen, F.T.; Lloyd, E.A.; Mabin, T.; Commerford, P.J.; Eichler, H.G. 1985: Tiapamil--a new calcium antagonist South African Medical Journal 67(22): 881-883
Sviatov, I.S.; Shilov, A.M. 1996: Magnesium: a natural calcium antagonist Klinicheskaia Meditsina 74(3): 54-56
Robbens, E.J.; Hagemeijer, F. 1986: Diltiazem: a new calcium antagonist in the Netherlands Nederlands Tijdschrift Voor Geneeskunde 130(12): 535-537
Bohl, E. 1982: Dilzem - a new calcium antagonist is introduced Zfa. Zeitschrift für Allgemeinmedizin 58(5): 292-296
Millar, J.A.; Bramley, P.M. 1984: Clinical pharmacology of calcium antagonists Methods and Findings in Experimental and Clinical Pharmacology 6(4): 205-211
Kuwahara, T.; Kawai, C.; Matsunaga, M. 1985: Pharmacology of calcium channel blockers Nihon Rinsho. Japanese Journal of Clinical Medicine 43(5): 978-982
Hirakawa, K.; Unno, T.; Ogino, F.; Takebe, H.; Iino, T.; Nose, T. 1982: Acute toxicity study of KB-944, a new calcium antagonist Arzneimittel-Forschung 32(9): 1068-1070